Table 1.

HIV vaccine attribute profiles across three groups

HIV vaccine attributes	Multiethnic Los Angeles group (n = 143)	Los Angeles-Thai community group (n = 27)	Aboriginal peoples-Toronto group (n = 13)
Efficacy	95% versus 50%	99% versus 50%	95% versus 50%
Cross-clade protection	Multiple types versus one type	Multiple types versus one type	Multiple types versus one type
Side-effects	None versus minor	None versus minor	None versus minor
Duration of protection	Lifetime versus 10 years	10 years versus 1 year	Lifetime versus 10 years
Numbers of doses	1 versus 3	1 versus 4	2 versus 5
Cost	US$10 versus US$50	Free versus US$250	US$10 versus US$100
Route of administration	Oral versus injection	Oral versus injection	–
Vaccine-induced     seropositivity	–	–	Test HIV+ for 3 months versus test HIV+     for 2 years